Dosage and administration
Before, during and/or after pregnancy, one softgel daily or as directed by a licensed healthcare practitioner regardless of lactation status.
WesCap-PN DHA
- Manufacturer
- Westminster Pharmaceuticals, LLC
- Effective date
- 2021-12-17
- Label type
- DIETARY SUPPLEMENT
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 02:50:17
Label at a glance#
ProductWesCap-PN DHA
Active ingredientASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL, D-, PYRIDOXINE HYDROCHLORIDE, LEVOMEFOLATE CALCIUM, FOLIC ACID, CYANOCOBALAMIN, CALCIUM CARBONATE, FERROUS FUMARATE, MAGNESIUM OXIDE, DOCONEXENT
Label structure11 sections
Contacts and useful links#
Label contents#
Full prescribing information#
STATEMENT OF IDENTITY SECTION
| Supplement Facts | ||
|---|---|---|
| Serving Size: 1 Softgel | ||
| Amount Per Serving | % Daily Value for Pregnant and Lactating Women | |
| Vitamin C (ascorbic Acid) | 85 mg | 71% |
| Vitamin D (Vitamin D3 as Cholecalciferol) | 5 mcg (200 IU) | 33% |
| Vitamin E (d-alpha tocopherol) | 6.7 mg (10 IU) | 35% |
| Vitamin B6 (pyridoxine HCl) | 25 mg | 1250% |
| Folate (L-Methylfolate Calcium, or 6(S)-5-MTHF-Ca 600 mcg) (folic acid, USP 400 mcg) | 1700 mcg DFE (400 mcg Folic Acid) | 283% |
| Vitamin B12 (cyanocobalamin) | 12 mcg | 429% |
| Calcium (calcium carbonate) | 140 mg | 11% |
| Iron (ferrous fumarate) | 27 mg | 100% |
| Magnesium (magnesium oxide) | 45 mg | 11% |
| Docosahexaenoic Acid (DHA) | 300 mg* | † |
Other Ingredients: Gelatin, Soybean Oil, Glycerin, Purified Water, Soy Lecithin, Titanium Dioxide, Yellow Beeswax, Natural Creamy Orange Flavor, FD&C Yellow #6, Ethyl Vanillin, FD&C Red #40.
DESCRIPTION
WesCap-PN DHA is a prescription prenatal/postnatal multivitamin/mineral dietary supplement with fishbased DHA and should be administered under the supervision of a licensed medical practitioner.
DOSAGE AND ADMINISTRATION
Before, during and/or after pregnancy, one softgel daily or as directed by a licensed healthcare practitioner regardless of lactation status.
CAUTION
Ingestion of more than 3 grams per day of omega-3 fatty acids (ALA, EPA, and DHA) may have potential antithrombotic activities, or effects, and may increase bleeding times. Administration of omega-3 fatty acids, including DHA, should be avoided in patients with inherited or acquired bleeding diathesis, including those taking anticoagulants. Exercise caution to ensure that the prescribed dosage of DHA does not exceed 1 gram (1000 mg) per day.
WARNINGS SECTION
| WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately. |
CAUTION
High levels of folic acid may, especially in older adults, hide signs of Vitamin B-12 deficiency (such as pernicious anemia), a condition that can cause nerve damage.
STORAGE
Store at 20° to 25°C (68° to 77°F). Excursions permitted to 15° to 30°C (59° to 86°F). Protect from light and moisture. Dispense in a tight, light-resistant container.
HEALTH CLAIM SECTION
Call your licensed medical practitioner about side effects. You may report side effects by calling Westminster Pharmaceuticals LLC, at 1-844-221-7294 or FDA AT 1-800-FDA-1088.
HOW SUPPLIED
Supplied as oblong, orange-colored softgel, imprinted "316" and dispensed in 30 count bottles.
HEALTH CLAIM SECTION
Manufactured for:
Westminster Pharmaceuticals, LLC
Nashville, TN 37217
Rev. 09/21
PRINCIPAL DISPLAY PANEL - 30 Softgel Bottle Label
69367-316-30
Rx
WesCap-PN DHA
PRENATAL/POSTNATAL
Prescription Multivitamin/Mineral
Dietary Supplement with
Fish-Based DHA
30 Softgels
Westminster
Pharmaceuticals
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| ASCORBIC ACID Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| CALCIUM CATION Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20230427 |
| CHOLECALCIFEROL Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| CYANOCOBALAMIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| LEVOMEFOLIC ACID Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20230428 |
| MAGNESIUM CATION Pharmacologic Class Indexing | 4 | Indexing - Pharmacologic Class | 20180813 |
| PYRIDOXINE Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20170310 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69367-316-30 | WesCap-PN DHA | 30 in 1 BOTTLE, PLASTIC | CAPSULE, GELATIN COATED | 30 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 69367-316 | WESCAP-PN DHA (ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL, D-, PYRIDOXINE HYDROCHLORIDE, LEVOMEFOLATE CALCIUM, FOLIC ACID, CYANOCOBALAMIN, CALCIUM CARBONATE, FERROUS FUMARATE, MAGNESIUM OXIDE, AND DOCONEXENT) CAPSULE, GELATIN COATED [WESTMINSTER PHARMACEUTICALS, LLC] | 1 | 1 package rows | 20211223_5e877e49-2fc1-412e-9e56-581147a325dd.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 69367-316-30 | EA - Each | 69367-316 | 323ef7c5-52f7-4af0-a28d-3c5d10b93407 | 1 | 2022-02-07 |
Products#
Every source-derived product name is available through these pages.
- WesCap-PN DHA
- ascorbic acid, cholecalciferol, .alpha.-tocopherol, d-, pyridoxine hydrochloride, levomefolate calcium, folic acid, cyanocobalamin, calcium carbonate, ferrous fumarate, magnesium oxide, and doconexent
- ASCORBIC ACID
- CHOLECALCIFEROL
- .ALPHA.-TOCOPHEROL, D-
- PYRIDOXINE HYDROCHLORIDE
- PYRIDOXINE
- LEVOMEFOLATE CALCIUM
- LEVOMEFOLIC ACID
- FOLIC ACID
- CYANOCOBALAMIN
- CALCIUM CARBONATE
- CALCIUM CATION
- FERROUS FUMARATE
- FERROUS CATION
- MAGNESIUM OXIDE
- MAGNESIUM CATION
- DOCONEXENT
- YELLOW WAX
- SOYBEAN OIL
- GELATIN, UNSPECIFIED
- GLYCERIN
- WATER
- TITANIUM DIOXIDE
- LECITHIN, SOYBEAN
- ETHYL VANILLATE
- FD&C RED NO. 40
- FD&C YELLOW NO. 6
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 69367-316 | 69367-316-30 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ascorbic Acid | ASCORBIC ACID | Renova Pharmaceuticals LLC | a6481bae-2397-44c7-a51d-4f47ad91bd2c | 2026-08-19 | Warnings, Adverse reactions | ASCORBIC ACID |
| Ascor | ASCORBIC ACID | McGuff Pharmaceuticals, Inc. | 388aad52-fc01-4784-9791-1dbc80c69306 | 2026-05-29 | Warnings, Adverse reactions | ASCORBIC ACID |
| Ascorbic Acid | ASCORBIC ACID | Fresenius Kabi USA, LLC | 1606e29f-0e80-4069-b688-daab9cbff20a | 2025-12-17 | Warnings, Adverse reactions | ASCORBIC ACID |
| Skin Renewing Serum | ASCORBIC ACID | Guangzhou Danting Bath&Body Care Industry Co. Ltd | 396c2a8d-ac95-cbef-e063-6294a90aff39 | 2025-08-23 | Warnings | ASCORBIC ACID |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.